AI assistant
BTC HEALTH LTD — Net Asset Value 2012
Sep 2, 2012
64575_rns_2012-09-02_9d409478-6616-4f27-95e8-7ea9b74a3f5c.pdf
Net Asset Value
Open in viewerOpens in your device viewer
==> picture [135 x 99] intentionally omitted <==
03 September 2012: Net Tangible Asset (NTA) Backing – August 2012
| 31 August 2012 | 31 August 2012 | Cost Price | Cost Price | Board Valuation1 |
|---|---|---|---|---|
| Company | ASX Code | Cost Price Cents per BTC share |
Current Value Cents per BTC share* |
|
| UNLISTED SECURITIES 1 Biocomm 2 Sensear General Provision TOTAL UNLISTED SECURITIES Cash |
1,235,701 $ 1.66c 3,116,761 $ 4.18c 0.00c |
221,775 $ 0.30c 3,338,984 $ 4.48c - $ 0.00c |
||
| 4,352,462 $ 5.84c |
3,560,759 $ 4.78c |
|||
| 1,292,999 $ 1.73c |
1,292,999 $ 1.73c |
|||
| Tax Provision | - $ 0.00c |
- $ 0.00c |
||
| TOTAL | 5,645,461 $ 7.57c |
4,853,757 $ 6.51c |
1 Board Valuation as defined by BioTech Capital's Investment policy including provision for tax
BioTech Capital issued capital: Ordinary Shares 74,554,108
Commentary - activities during the last month
Proceeds from the voluntary wind-up of Biocomm Services Pty Ltd are not likely to be received until later in 2012 given the statutory process and timeline that must be adhered to before liquidating the company and disbursing net surplus funds to underlying shareholders. The figure in the table above represents the most likely distribution to be received by BTC based on all information currently at hand.
This leaves one remaining investment being Sensear Pty Ltd. The Board is actively pursuing an appropriate exit mechanism for this stake.
Valuations
The “Board Valuation” column is based upon the investment policy of the Board and is broadly in line with industry standard practices.
About BioTech Capital Ltd
BioTech Capital Ltd (“BTC”) is a listed investment fund currently conducting an orderly wind-down of its holdings pursuant to a change in investment activity approved by shareholders in 2010. As a registered Pooled Development Fund (PDF), investors are generally exempt from tax on capital gains and income. BTC is listed on the Australian Stock Exchange (Code: BTC). Additional information can be found at www.biotechcapital.com.au
Contact Information
Harry Karelis, Director, Biotech Capital Ltd, Ph: +61 413 056 328, E-mail: [email protected]
Biotech Capital Limited ABN 45 091 979 172 www.biotechcapital.com.au
1 Edmondson Crescent T +61 413 056 328 Karrinyup WA 6018 F +61 8 9327 1778 Australia